Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06110351 · ClinicalTrials.gov registry record
Acute Clinical Outcomes of Hemorrhagic Myocardial Infarction
A clinical trial of Acute Myocardial Infarction, sponsored by Indiana University.
- Completed
- Registry status
- 12,000
- Enrollment target
- 1
- Study location
NCT06110351: Completed study of Acute Myocardial Infarction, sponsored by Indiana University.
NCT06110351 is a study of Acute Myocardial Infarction that has completed, run by Indiana University. The registered enrollment target is 12,000 participants, above the 1,251-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (859% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06110351, a study of Acute Myocardial Infarction, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 12,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Acute clinical outcomes 1. Mortality 2. Arrhythmia 3. Readmission 4. CVA 5. ADHF
Primary Outcome
Prevalence of acute mortality
Conditions Studied
Study Locations (1)
Indiana
- IU Methodist Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,000 participants |
| Start Date | 2023-11-08 |
| Est. Completion | 2024-12-15 |
What the finished NCT06110351 record still lists
NCT06110351 is an observational study that tracks outcomes without assigning an intervention. Its 12,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,251-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (859% higher).
The record links to 1 condition, with Acute Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.
NCT06110351 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT06110351 about?
NCT06110351 is a clinical study titled "Acute Clinical Outcomes of Hemorrhagic Myocardial Infarction". Acute clinical outcomes 1. Mortality 2. Arrhythmia 3. Readmission 4. CVA 5. ADHF
What is the current status of trial NCT06110351?
This trial is currently completed. The enrollment target is 12,000 participants. The study started on 2023-11-08. Estimated completion is 2024-12-15.
What conditions does trial NCT06110351 study?
This clinical trial studies the following conditions: Acute Myocardial Infarction.
Who is sponsoring clinical trial NCT06110351?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06110351 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06110351's enrollment target sits among peer trials
12,000 1st of 19 higher than 19 of 19 other Acute Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
RECRUITING · NA
-
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
RECRUITING
-
Abbott Vascular Medical Device Registry
RECRUITING
-
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
RECRUITING · NA
-
Arrhythmia Detection After MI
RECRUITING · NA
-
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
- NCT06273618 · 12,000 participants · NA
iLookOut Micro-learning to Improve Knowledge Retention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI